![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/SMSLIFE.png)
Share the post "SMS Lifesciences India ‘s Q2 Financial results: Revenue Grows by 13.28% YoY"
Highlights
- The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 13.28 % in the past year, decrease in net sales/revenue by -15.22 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 506.85 %. Marginal increase in other income during this quarter, up by 364.46%.
- Profit over the Year and quarter: Challenges in sustaining profitability for SMS Lifesciences India Limited. Profit dropped by -844.92 % Year to Year, SMS Lifesciences India Limited’s profitability dropped by -53.49 % Quarter to Quarter.
- EPS over the Year and quarter: EPS increased by 602.73 % Year to Year. EPS decreased by -33.22 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 69.261 Cr | Rs. 92.548 Cr | Rs. 78.462 Cr | -15.22 % | + 13.28 % |
| Expenses | Rs. 61.39 Cr | Rs. 76.26 Cr | Rs. 69.89 Cr | -8.35 % | + 13.85 % |
| Operating Profit | Rs. 7.87 Cr | Rs. 16.29 Cr | Rs. 8.57 Cr | -47.39 % | + 8.89 % |
| OPM % | 11.36 % | 17.6 % | 10.92 % | -6.68 % | -0.44 % |
| Other Income | Rs. 0.336 Cr | Rs. 0.439 Cr | Rs. 2.039 Cr | + 364.46 % | + 506.85 % |
| Interest | Rs. 2.81 Cr | Rs. 2.41 Cr | Rs. 2.14 Cr | -11.2 % | -23.84 % |
| Depreciation | Rs. 3.73 Cr | Rs. 3.68 Cr | Rs. 3.76 Cr | + 2.17 % | + 0.8 % |
| Profit before tax | Rs. 1.67 Cr | Rs. 10.64 Cr | Rs. 4.71 Cr | -55.73 % | + 182.04 % |
| Tax % | 126.63 % | 33.31 % | 29.85 % | -3.46 % | -96.78 % |
| Net Profit | Rs. -0.44 Cr | Rs. 7.1 Cr | Rs. 3.3 Cr | -53.52 % | + 850 % |
| EPS in Rs | Rs. -2.2 | Rs. 23.15 | Rs. 15.46 | -33.22 % | + 802.73 % |
Today, we’re looking at SMS Lifesciences India Limited’s financial performance for the Q2(Sep 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 13.28 %. However, it did see a marginal slip of -15.22 % from the previous quarter. Expenses decreased slightly by -8.35 % quarter-on-quarter, aligning with the annual rise of 13.85 %. Operating profit, while up 8.89 % compared to last year, faced a quarter-on-quarter dip of -47.39 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -0.44 %, but a shrinkage of -6.68 % sequentially. Other income rose by 364.46 % compared to the last quarter, despite an annual growth of 506.85 %. Interest expenses dropped significantly by -11.2 % from the previous quarter, yet the year-over-year decrease remains at a moderate -23.84 %. Depreciation costs climbed by 2.17 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 0.8 %. Profit before tax grew annually by 182.04 % but saw a reduction from the preceding quarter by -55.73 %.
Tax expenses as a percentage of profits decreased slightly by -96.78 % compared to last year, with a more notable quarter-on-quarter decrease of -3.46 %. Net profit rose by 850 % year-on-year but witnessed a -53.52 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 802.73 % but a quarterly fall of -33.22 %. In summary, SMS Lifesciences India Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 69.261 Cr | Rs. 92.548 Cr | Rs. 78.462 Cr | -15.22 % | + 13.28 % |
| Expenses | Rs. 61.39 Cr | Rs. 76.26 Cr | Rs. 69.89 Cr | -8.35 % | + 13.85 % |
| Operating Profit | Rs. 7.87 Cr | Rs. 16.29 Cr | Rs. 8.57 Cr | -47.39 % | + 8.89 % |
| Net Profit | Rs. -0.44 Cr | Rs. 7.1 Cr | Rs. 3.3 Cr | -53.52 % | + 850 % |
| EPS in Rs | Rs. -2.2 | Rs. 23.15 | Rs. 15.46 | -33.22 % | + 802.73 % |
In reviewing SMS Lifesciences India Limited’s 2024-25(Q2) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 13.28 % year-on-year growth, although there was a slight dip of -15.22 % from the previous quarter. Expenses rose by 13.85 % compared to the previous year, with a decrease of -8.35 % quarter-on-quarter. Operating Profit surged by 8.89 % annually, and saw a -47.39 % decrease from the last quarter.
Net Profit showed yearly increase of 850 %, and experienced a -53.52 % decrease from the previous quarter. Earnings Per Share (EPS) rose by 802.73 % annually, however dipped by -33.22 % compared to the last quarter. In essence, while SMS Lifesciences India Limited exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
[my_shortcode1 values=”SMS Lifesciences India Limited”]
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/shareholding/6584c1a376ed26f37a120d2f_mural-blog-images (16) (2).jpg)